MedPath
NMPA Approval

N/A

国药准字Z44020298

September 25, 2019

Drug Information

通脉颗粒

白云山

颗粒剂

每袋装10g

中药

September 25, 2019

Company Information

Applicant Company

Manufacturing Company

广州市黄埔区云埔一路32号

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

通脉颗粒 - NMPA 批准文号 | MedPath